Global WholeHealth Partners Corp (OTC:GWHP) Secures Global Distribution Rights to Sell the AstraZeneca COVID-19 Vaccine Anywhere in the World Pending FDA Approval as Biden Administration Stockpiles Vaccine

Press Release

San Clemente, CA – (NewMediaWire) – March 17, 2021 – Global WholeHealth Partners Corp. (OTC:GWHP), a multinational supplier of over 70+ FDA approved tests including Dengue, Ebola, Zika, Malaria and also offering one of the largest lines of tests for CoViD19 SARS2, is prepared to help in the fight against CoViD19 SARS2. With the vaccine rollout in progress, continued testing for COVID-19 is imperative and needs to remain a top priority to stop the spread of this deadly virus.Global WholeHealth Partners, Corp (OTC:GWHP) Secures Distribution Rights to sell the AstraZeneca COVID-19 Vaccine anywhere in the world pending FDA Approval as Biden Administration Increases Stockpile in preparation of a quick roll out.Charles Strongo, CEO of Global WholeHealth Partners, Corp., said, “We were so impressed by the progress that AstraZeneca has made thus far with their vaccine, that we (Global) have acquired the distribution rights to sell this vaccine anywhere in the world.”“We think the Biden Administration is being strategically proactive with their plan to accumulate the AstraZeneca vaccines ahead of time,” Charles Strongo commented.White House press secretary Jen Psaki recently said, “We want to be oversupplied and overprepared,” saying Biden wanted contingencies in the event of any unforeseen issues with the existing production timeline.A copy of the Global WholeHealth Partners, Corp 8K filing related to the distribution rights of the AstraZeneca vaccine can be found here.“The CDC is still recommending that individuals who are already fully vaccinated for the COVID-19 virus continue to get tested if they are experiencing any of the symptoms,” Charles Strongo reiterated.CDC Recommendations for Fully Vaccinated People can be found here.“There is no better way to Stop the Spread of COVID-19 and its various mutated strains then by utilizing the rapid antibody test kits that we offer to accurately detect those who have become infected and having them immediately quarantine,” says Charles Strongo, CEO of Global WholeHealth Partners, Corp.Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.With results in minutes versus hours or days with other diagnostic kits, the more lives that can be saved with the only FDA authorized COVID-19 POC serology Point of Care Test. With the new fingerstick test, healthcare providers can prick a patient’s finger and get results in minutes without having to wait for venous blood. Global WholeHealth Partners will be able to distribute these tests to more urgent cares, hospitals, and – to help curb the spread of CoViD19 SARS2.Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. Notably, GWHP offers a CE Mark for its high quality, rapid antibody test for COVID-19 and an EUA filing with the FDA is pending approval. In the interim, the US Navy in California has been using the test during 2Q20 and the Company has the capacity to deliver hundreds of thousands of tests, ramping up to 1 million per day. Currently, the Company has 56 products FDA approved and many are Approved for OTC use, and 9 POC products approved by the FDA.Disclaimer:The Company is not making any express or implied claims that its …